BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.91
Delayed Data
As of Apr 20
 +0.07 / +1.45%
Today’s Change
3.95
Today|||52-Week Range
7.39
0.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-45.2M-43.0M-55.1M-65.8M
 
 
 
 
 
Depreciation177.0K180.0K483.0K704.0K
 
 
 
 
 
Total Other Cash Flow5.2M10.7M8.8M14.6M
 
 
 
 
 
Funds From Operations-39.9M-32.1M-45.9M-50.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.3M-19.0M7.6M-9.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-38.6M-13.1M-53.4M-41.1M
 
 
 
 
 
 
InvestingIncrease In Investments-73.9M-53.8M-14.1M-107.8M
 
 
 
 
 
Decrease In Investments34.0M42.4M42.7M43.5M
 
 
 
 
 
Capital Expenditures-106.0K-5.1M-5.3M-328.0K
 
 
 
 
 
Fixed Asset Disposal0.000.004.0K12.0K
 
 
 
Other Investing - Sources1.0K0.000.000.00
 
 
Net Cash Flow Investing-40.0M-16.5M23.3M-64.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-1.5M--0.00
 
 
Long Term Borrowings0.000.0023.0M122.0K
 
 
 
Long Term Debt Reduction0.000.00------
Net Proceeds Stock Sale111.9M5.5M317.0K135.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing111.9M4.0M23.3M135.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash33.4M-25.6M-6.9M29.9M